Clene director granted 3,514 stock options at $4.19
Clene Inc. director Vallerie McLaughlin received a stock option grant for 3,514 shares of common stock on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clene Inc. director Vallerie McLaughlin received a stock option grant for 3,514 shares of common stock on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan. The option has an exercise price of $4.19 per share, vests immediately upon grant, and expires on August 12, 2036. Following this grant, she holds options for 3,514 shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | stock option F1 | 3,514 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.
Key Figures
Key Terms
stock option financial
exercise price financial
Amended 2020 Stock Plan financial
vest immediately upon grant financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Clene Inc. (CLNN) disclose in this Form 4 for Vallerie McLaughlin?
What is the exercise price of the new Clene Inc. (CLNN) stock options?
When do Vallerie McLaughlin’s new Clene Inc. (CLNN) stock options vest and expire?
What is Vallerie McLaughlin’s Clene Inc. (CLNN) option holding after this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.